PMID- 37429439
OWN - NLM
STAT- MEDLINE
DCOM- 20230911
LR  - 20230916
IS  - 1874-1754 (Electronic)
IS  - 0167-5273 (Linking)
VI  - 390
DP  - 2023 Nov 1
TI  - Two-incision totally thoracoscopic mitral valve repair combined with 
      radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: 
      Early results of a case series of 43 consecutive patients.
PG  - 131158
LID - S0167-5273(23)00965-8 [pii]
LID - 10.1016/j.ijcard.2023.131158 [doi]
AB  - BACKGROUND: Few studies have reported the outcomes of two-incision total 
      thoracoscopic mitral valve repair (MVr) and concomitant radiofrequency atrial 
      fibrillation ablation (RAFA) in patients with rheumatic mitral valve disease and 
      atrial fibrillation (AF). METHODS: We retrospectively analyzed 43 consecutive 
      patients who underwent MVr and RAFA through two-incision total thoracoscopic 
      technique from October 2018 to June 2022. We collected data on baseline 
      characteristics, perioperative outcomes, and early-term results. RESULTS: The 
      mean age was 55.67 +/- 7.64 years and 29 (67.4%) patients had New York Heart 
      Association (NYHA) class III or IV. The mean cardiopulmonary bypass (CPB) time 
      was 115.56 +/- 8.53 min and aortic clamping time was 81.42 +/- 7.54 min. There were 
      no in-hospital deaths or strokes. The mean preoperative mitral valve orifice area 
      (MVOA) was 0.95 (0.84-1.16) cm2 and increased to 2.56 (2.41-2.87) cm2 at 
      discharge and 2.54 (2.44-2.76) cm2 at 3 months after surgery (P < .001). At 
      discharge, 32 (74.4%) patients were in sinus rhythm, 7 (20.9%) were in junctional 
      or atrial flutter rhythm, and 4 (9.3%) remained in AF. At 6 months, 35 (81.4%) 
      patients were in sinus rhythm, 5 (11.63%) were in junctional or atrial flutter 
      rhythm, and 3 (4.7%) were in AF. CONCLUSIONS: Two-incision total thoracoscopic 
      MVr and RAFA is a safe and effective procedure that can improve the MVOA and 
      promote conversion of AF to sinus rhythm in patients with rheumatic mitral valve 
      disease and AF. Further studies with larger sample size and longer follow-up are 
      needed to confirm the long-term benefits of this approach.
CI  - Copyright (c) 2023 Elsevier B.V. All rights reserved.
FAU - Xu, Zheng
AU  - Xu Z
AD  - Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, 
      Fuzhou 350001, PR China; Key Laboratory of Cardio-Thoracic Surgery, Fujian 
      Medical University, Fujian Province University, Fuzhou 350001, PR China.
FAU - Dai, Xiao-Fu
AU  - Dai XF
AD  - Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, 
      Fuzhou 350001, PR China; Key Laboratory of Cardio-Thoracic Surgery, Fujian 
      Medical University, Fujian Province University, Fuzhou 350001, PR China.
FAU - Lin, Feng
AU  - Lin F
AD  - Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, 
      Fuzhou 350001, PR China.
FAU - Chen, Liang-Wan
AU  - Chen LW
AD  - Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, 
      Fuzhou 350001, PR China; Key Laboratory of Cardio-Thoracic Surgery, Fujian 
      Medical University, Fujian Province University, Fuzhou 350001, PR China.
FAU - Lin, Zhi-Qin
AU  - Lin ZQ
AD  - Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, 
      Fuzhou 350001, PR China. Electronic address: zhiqinemail@163.com.
LA  - eng
PT  - Journal Article
DEP - 20230708
PL  - Netherlands
TA  - Int J Cardiol
JT  - International journal of cardiology
JID - 8200291
SB  - IM
MH  - Humans
MH  - Middle Aged
MH  - Mitral Valve/diagnostic imaging/surgery
MH  - *Atrial Fibrillation/diagnosis/surgery/complications
MH  - Retrospective Studies
MH  - *Atrial Flutter/surgery
MH  - Treatment Outcome
MH  - *Heart Valve Diseases/complications/surgery
MH  - *Rheumatic Heart Disease/complications/diagnosis/surgery
MH  - *Catheter Ablation/methods
MH  - Thoracoscopy
OTO - NOTNLM
OT  - Atrial fibrillation
OT  - Radiofrequency ablation
OT  - Rheumatic mitral valve disease
OT  - Total thoracoscopic mitral valve repair
COIS- Declaration of Competing Interest None declared.
EDAT- 2023/07/11 01:07
MHDA- 2023/09/11 06:42
CRDT- 2023/07/10 19:23
PHST- 2023/04/16 00:00 [received]
PHST- 2023/06/07 00:00 [revised]
PHST- 2023/07/05 00:00 [accepted]
PHST- 2023/09/11 06:42 [medline]
PHST- 2023/07/11 01:07 [pubmed]
PHST- 2023/07/10 19:23 [entrez]
AID - S0167-5273(23)00965-8 [pii]
AID - 10.1016/j.ijcard.2023.131158 [doi]
PST - ppublish
SO  - Int J Cardiol. 2023 Nov 1;390:131158. doi: 10.1016/j.ijcard.2023.131158. Epub 
      2023 Jul 8.